Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
TruScreen Group Ltd. ( (AU:TRU) ) has shared an update.
TruScreen Group Limited has announced a change in the date of their Special Meeting of Shareholders, which will now take place on July 15, 2025, instead of the previously scheduled July 11. The meeting will be conducted online. This change reflects the company’s ongoing commitment to maintaining transparent and accessible communication with its stakeholders, ensuring that shareholders can participate in important company decisions.
More about TruScreen Group Ltd.
TruScreen Group Limited is a medical device company specializing in AI-enabled technology for real-time detection of cervical tissue abnormalities. Their primary product, the TruScreen Ultra, is a non-invasive cervical cancer screening device that eliminates the need for biological tissue sampling and processing. The device is certified and approved for clinical use in multiple countries, including Australia, the UK, China, and others, and has been integrated into national health guidelines in Vietnam and Russia.
Average Trading Volume: 388,827
Technical Sentiment Signal: Sell
Current Market Cap: A$12.4M
See more data about TRU stock on TipRanks’ Stock Analysis page.